Global Short Bowel Syndrome (SBS) Market Insights and Forecast to 2028

Publisher Name :
Date: 28-Feb-2022
No. of pages: 91
Inquire Before Buying

Short Bowel Syndrome(SBS) market is segmented by players, region (country), by Type and by Sale Channel. Players, stakeholders, and other participants in the global Short Bowel Syndrome(SBS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Sale Channel for the period 2017-2028.

Segment by Type

- Oral Route

- Parental Route

Segment by Sale Channel

- Hospitals

- Clinics

- Retail Pharmacies

By Company

- Merck

- Takeda

- Emmaus Medical

- Ardelyx

- Naia Pharmaceuticals

- Nutrinia

- OxThera

- Sancilio Pharmaceuticals

- Zealand Pharma

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Short Bowel Syndrome (SBS) Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Short Bowel Syndrome(SBS) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Route
1.2.3 Parental Route
1.3 Market by Sale Channel
1.3.1 Global Short Bowel Syndrome(SBS) Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Short Bowel Syndrome(SBS) Market Perspective (2017-2028)
2.2 Short Bowel Syndrome(SBS) Growth Trends by Region
2.2.1 Short Bowel Syndrome(SBS) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Short Bowel Syndrome(SBS) Historic Market Size by Region (2017-2022)
2.2.3 Short Bowel Syndrome(SBS) Forecasted Market Size by Region (2023-2028)
2.3 Short Bowel Syndrome(SBS) Market Dynamics
2.3.1 Short Bowel Syndrome(SBS) Industry Trends
2.3.2 Short Bowel Syndrome(SBS) Market Drivers
2.3.3 Short Bowel Syndrome(SBS) Market Challenges
2.3.4 Short Bowel Syndrome(SBS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Short Bowel Syndrome(SBS) Players by Revenue
3.1.1 Global Top Short Bowel Syndrome(SBS) Players by Revenue (2017-2022)
3.1.2 Global Short Bowel Syndrome(SBS) Revenue Market Share by Players (2017-2022)
3.2 Global Short Bowel Syndrome(SBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Short Bowel Syndrome(SBS) Revenue
3.4 Global Short Bowel Syndrome(SBS) Market Concentration Ratio
3.4.1 Global Short Bowel Syndrome(SBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Short Bowel Syndrome(SBS) Revenue in 2021
3.5 Short Bowel Syndrome(SBS) Key Players Head office and Area Served
3.6 Key Players Short Bowel Syndrome(SBS) Product Solution and Service
3.7 Date of Enter into Short Bowel Syndrome(SBS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Short Bowel Syndrome(SBS) Breakdown Data by Type
4.1 Global Short Bowel Syndrome(SBS) Historic Market Size by Type (2017-2022)
4.2 Global Short Bowel Syndrome(SBS) Forecasted Market Size by Type (2023-2028)
5 Short Bowel Syndrome(SBS) Breakdown Data by Sale Channel
5.1 Global Short Bowel Syndrome(SBS) Historic Market Size by Sale Channel (2017-2022)
5.2 Global Short Bowel Syndrome(SBS) Forecasted Market Size by Sale Channel (2023-2028)
6 North America
6.1 North America Short Bowel Syndrome(SBS) Market Size (2017-2028)
6.2 North America Short Bowel Syndrome(SBS) Market Size by Type
6.2.1 North America Short Bowel Syndrome(SBS) Market Size by Type (2017-2022)
6.2.2 North America Short Bowel Syndrome(SBS) Market Size by Type (2023-2028)
6.2.3 North America Short Bowel Syndrome(SBS) Market Share by Type (2017-2028)
6.3 North America Short Bowel Syndrome(SBS) Market Size by Sale Channel
6.3.1 North America Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022)
6.3.2 North America Short Bowel Syndrome(SBS) Market Size by Sale Channel (2023-2028)
6.3.3 North America Short Bowel Syndrome(SBS) Market Share by Sale Channel (2017-2028)
6.4 North America Short Bowel Syndrome(SBS) Market Size by Country
6.4.1 North America Short Bowel Syndrome(SBS) Market Size by Country (2017-2022)
6.4.2 North America Short Bowel Syndrome(SBS) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Short Bowel Syndrome(SBS) Market Size (2017-2028)
7.2 Europe Short Bowel Syndrome(SBS) Market Size by Type
7.2.1 Europe Short Bowel Syndrome(SBS) Market Size by Type (2017-2022)
7.2.2 Europe Short Bowel Syndrome(SBS) Market Size by Type (2023-2028)
7.2.3 Europe Short Bowel Syndrome(SBS) Market Share by Type (2017-2028)
7.3 Europe Short Bowel Syndrome(SBS) Market Size by Sale Channel
7.3.1 Europe Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022)
7.3.2 Europe Short Bowel Syndrome(SBS) Market Size by Sale Channel (2023-2028)
7.3.3 Europe Short Bowel Syndrome(SBS) Market Share by Sale Channel (2017-2028)
7.4 Europe Short Bowel Syndrome(SBS) Market Size by Country
7.4.1 Europe Short Bowel Syndrome(SBS) Market Size by Country (2017-2022)
7.4.2 Europe Short Bowel Syndrome(SBS) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Short Bowel Syndrome(SBS) Market Size (2017-2028)
8.2 Asia-Pacific Short Bowel Syndrome(SBS) Market Size by Type
8.2.1 Asia-Pacific Short Bowel Syndrome(SBS) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Short Bowel Syndrome(SBS) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Short Bowel Syndrome(SBS) Market Share by Type (2017-2028)
8.3 Asia-Pacific Short Bowel Syndrome(SBS) Market Size by Sale Channel
8.3.1 Asia-Pacific Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022)
8.3.2 Asia-Pacific Short Bowel Syndrome(SBS) Market Size by Sale Channel (2023-2028)
8.3.3 Asia-Pacific Short Bowel Syndrome(SBS) Market Share by Sale Channel (2017-2028)
8.4 Asia-Pacific Short Bowel Syndrome(SBS) Market Size by Region
8.4.1 Asia-Pacific Short Bowel Syndrome(SBS) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Short Bowel Syndrome(SBS) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Short Bowel Syndrome(SBS) Market Size (2017-2028)
9.2 Latin America Short Bowel Syndrome(SBS) Market Size by Type
9.2.1 Latin America Short Bowel Syndrome(SBS) Market Size by Type (2017-2022)
9.2.2 Latin America Short Bowel Syndrome(SBS) Market Size by Type (2023-2028)
9.2.3 Latin America Short Bowel Syndrome(SBS) Market Share by Type (2017-2028)
9.3 Latin America Short Bowel Syndrome(SBS) Market Size by Sale Channel
9.3.1 Latin America Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022)
9.3.2 Latin America Short Bowel Syndrome(SBS) Market Size by Sale Channel (2023-2028)
9.3.3 Latin America Short Bowel Syndrome(SBS) Market Share by Sale Channel (2017-2028)
9.4 Latin America Short Bowel Syndrome(SBS) Market Size by Country
9.4.1 Latin America Short Bowel Syndrome(SBS) Market Size by Country (2017-2022)
9.4.2 Latin America Short Bowel Syndrome(SBS) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Short Bowel Syndrome(SBS) Market Size (2017-2028)
10.2 Middle East & Africa Short Bowel Syndrome(SBS) Market Size by Type
10.2.1 Middle East & Africa Short Bowel Syndrome(SBS) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Short Bowel Syndrome(SBS) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Short Bowel Syndrome(SBS) Market Share by Type (2017-2028)
10.3 Middle East & Africa Short Bowel Syndrome(SBS) Market Size by Sale Channel
10.3.1 Middle East & Africa Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022)
10.3.2 Middle East & Africa Short Bowel Syndrome(SBS) Market Size by Sale Channel (2023-2028)
10.3.3 Middle East & Africa Short Bowel Syndrome(SBS) Market Share by Sale Channel (2017-2028)
10.4 Middle East & Africa Short Bowel Syndrome(SBS) Market Size by Country
10.4.1 Middle East & Africa Short Bowel Syndrome(SBS) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Short Bowel Syndrome(SBS) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Short Bowel Syndrome(SBS) Introduction
11.1.4 Merck Revenue in Short Bowel Syndrome(SBS) Business (2017-2022)
11.1.5 Merck Recent Developments
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Short Bowel Syndrome(SBS) Introduction
11.2.4 Takeda Revenue in Short Bowel Syndrome(SBS) Business (2017-2022)
11.2.5 Takeda Recent Developments
11.3 Emmaus Medical
11.3.1 Emmaus Medical Company Details
11.3.2 Emmaus Medical Business Overview
11.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Introduction
11.3.4 Emmaus Medical Revenue in Short Bowel Syndrome(SBS) Business (2017-2022)
11.3.5 Emmaus Medical Recent Developments
11.4 Ardelyx
11.4.1 Ardelyx Company Details
11.4.2 Ardelyx Business Overview
11.4.3 Ardelyx Short Bowel Syndrome(SBS) Introduction
11.4.4 Ardelyx Revenue in Short Bowel Syndrome(SBS) Business (2017-2022)
11.4.5 Ardelyx Recent Developments
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Details
11.5.2 Naia Pharmaceuticals Business Overview
11.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Introduction
11.5.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome(SBS) Business (2017-2022)
11.5.5 Naia Pharmaceuticals Recent Developments
11.6 Nutrinia
11.6.1 Nutrinia Company Details
11.6.2 Nutrinia Business Overview
11.6.3 Nutrinia Short Bowel Syndrome(SBS) Introduction
11.6.4 Nutrinia Revenue in Short Bowel Syndrome(SBS) Business (2017-2022)
11.6.5 Nutrinia Recent Developments
11.7 OxThera
11.7.1 OxThera Company Details
11.7.2 OxThera Business Overview
11.7.3 OxThera Short Bowel Syndrome(SBS) Introduction
11.7.4 OxThera Revenue in Short Bowel Syndrome(SBS) Business (2017-2022)
11.7.5 OxThera Recent Developments
11.8 Sancilio Pharmaceuticals
11.8.1 Sancilio Pharmaceuticals Company Details
11.8.2 Sancilio Pharmaceuticals Business Overview
11.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Introduction
11.8.4 Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome(SBS) Business (2017-2022)
11.8.5 Sancilio Pharmaceuticals Recent Developments
11.9 Zealand Pharma
11.9.1 Zealand Pharma Company Details
11.9.2 Zealand Pharma Business Overview
11.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Introduction
11.9.4 Zealand Pharma Revenue in Short Bowel Syndrome(SBS) Business (2017-2022)
11.9.5 Zealand Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Short Bowel Syndrome(SBS) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oral Route
Table 3. Key Players of Parental Route
Table 4. Global Short Bowel Syndrome(SBS) Market Size Growth Rate by Sale Channel (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Short Bowel Syndrome(SBS) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Short Bowel Syndrome(SBS) Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Short Bowel Syndrome(SBS) Market Share by Region (2017-2022)
Table 8. Global Short Bowel Syndrome(SBS) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Short Bowel Syndrome(SBS) Market Share by Region (2023-2028)
Table 10. Short Bowel Syndrome(SBS) Market Trends
Table 11. Short Bowel Syndrome(SBS) Market Drivers
Table 12. Short Bowel Syndrome(SBS) Market Challenges
Table 13. Short Bowel Syndrome(SBS) Market Restraints
Table 14. Global Short Bowel Syndrome(SBS) Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Short Bowel Syndrome(SBS) Revenue Share by Players (2017-2022)
Table 16. Global Top Short Bowel Syndrome(SBS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome(SBS) as of 2021)
Table 17. Ranking of Global Top Short Bowel Syndrome(SBS) Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Short Bowel Syndrome(SBS) Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Short Bowel Syndrome(SBS) Product Solution and Service
Table 21. Date of Enter into Short Bowel Syndrome(SBS) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Short Bowel Syndrome(SBS) Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Short Bowel Syndrome(SBS) Revenue Market Share by Type (2017-2022)
Table 25. Global Short Bowel Syndrome(SBS) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Short Bowel Syndrome(SBS) Revenue Market Share by Type (2023-2028)
Table 27. Global Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022) & (US$ Million)
Table 28. Global Short Bowel Syndrome(SBS) Revenue Share by Sale Channel (2017-2022)
Table 29. Global Short Bowel Syndrome(SBS) Forecasted Market Size by Sale Channel (2023-2028) & (US$ Million)
Table 30. Global Short Bowel Syndrome(SBS) Revenue Share by Sale Channel (2023-2028)
Table 31. North America Short Bowel Syndrome(SBS) Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Short Bowel Syndrome(SBS) Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022) & (US$ Million)
Table 34. North America Short Bowel Syndrome(SBS) Market Size by Sale Channel (2023-2028) & (US$ Million)
Table 35. North America Short Bowel Syndrome(SBS) Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Short Bowel Syndrome(SBS) Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Short Bowel Syndrome(SBS) Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Short Bowel Syndrome(SBS) Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022) & (US$ Million)
Table 40. Europe Short Bowel Syndrome(SBS) Market Size by Sale Channel (2023-2028) & (US$ Million)
Table 41. Europe Short Bowel Syndrome(SBS) Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Short Bowel Syndrome(SBS) Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Short Bowel Syndrome(SBS) Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Short Bowel Syndrome(SBS) Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022) & (US$ Million)
Table 46. Asia Pacific Short Bowel Syndrome(SBS) Market Size by Sale Channel (2023-2028) & (US$ Million)
Table 47. Asia Pacific Short Bowel Syndrome(SBS) Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Short Bowel Syndrome(SBS) Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Short Bowel Syndrome(SBS) Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Short Bowel Syndrome(SBS) Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022) & (US$ Million)
Table 52. Latin America Short Bowel Syndrome(SBS) Market Size by Sale Channel (2023-2028) & (US$ Million)
Table 53. Latin America Short Bowel Syndrome(SBS) Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Short Bowel Syndrome(SBS) Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Short Bowel Syndrome(SBS) Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Short Bowel Syndrome(SBS) Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Short Bowel Syndrome(SBS) Market Size by Sale Channel (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Short Bowel Syndrome(SBS) Market Size by Sale Channel (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Short Bowel Syndrome(SBS) Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Short Bowel Syndrome(SBS) Market Size by Country (2023-2028) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Short Bowel Syndrome(SBS) Product
Table 64. Merck Revenue in Short Bowel Syndrome(SBS) Business (2017-2022) & (US$ Million)
Table 65. Merck Recent Developments
Table 66. Takeda Company Details
Table 67. Takeda Business Overview
Table 68. Takeda Short Bowel Syndrome(SBS) Product
Table 69. Takeda Revenue in Short Bowel Syndrome(SBS) Business (2017-2022) & (US$ Million)
Table 70. Takeda Recent Developments
Table 71. Emmaus Medical Company Details
Table 72. Emmaus Medical Business Overview
Table 73. Emmaus Medical Short Bowel Syndrome(SBS) Product
Table 74. Emmaus Medical Revenue in Short Bowel Syndrome(SBS) Business (2017-2022) & (US$ Million)
Table 75. Emmaus Medical Recent Developments
Table 76. Ardelyx Company Details
Table 77. Ardelyx Business Overview
Table 78. Ardelyx Short Bowel Syndrome(SBS) Product
Table 79. Ardelyx Revenue in Short Bowel Syndrome(SBS) Business (2017-2022) & (US$ Million)
Table 80. Ardelyx Recent Developments
Table 81. Naia Pharmaceuticals Company Details
Table 82. Naia Pharmaceuticals Business Overview
Table 83. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Product
Table 84. Naia Pharmaceuticals Revenue in Short Bowel Syndrome(SBS) Business (2017-2022) & (US$ Million)
Table 85. Naia Pharmaceuticals Recent Developments
Table 86. Nutrinia Company Details
Table 87. Nutrinia Business Overview
Table 88. Nutrinia Short Bowel Syndrome(SBS) Product
Table 89. Nutrinia Revenue in Short Bowel Syndrome(SBS) Business (2017-2022) & (US$ Million)
Table 90. Nutrinia Recent Developments
Table 91. OxThera Company Details
Table 92. OxThera Business Overview
Table 93. OxThera Short Bowel Syndrome(SBS) Product
Table 94. OxThera Revenue in Short Bowel Syndrome(SBS) Business (2017-2022) & (US$ Million)
Table 95. OxThera Recent Developments
Table 96. Sancilio Pharmaceuticals Company Details
Table 97. Sancilio Pharmaceuticals Business Overview
Table 98. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Product
Table 99. Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome(SBS) Business (2017-2022) & (US$ Million)
Table 100. Sancilio Pharmaceuticals Recent Developments
Table 101. Zealand Pharma Company Details
Table 102. Zealand Pharma Business Overview
Table 103. Zealand Pharma Short Bowel Syndrome(SBS) Product
Table 104. Zealand Pharma Revenue in Short Bowel Syndrome(SBS) Business (2017-2022) & (US$ Million)
Table 105. Zealand Pharma Recent Developments
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Short Bowel Syndrome(SBS) Market Share by Type: 2021 VS 2028
Figure 2. Oral Route Features
Figure 3. Parental Route Features
Figure 4. Global Short Bowel Syndrome(SBS) Market Share by Sale Channel: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Short Bowel Syndrome(SBS) Report Years Considered
Figure 9. Global Short Bowel Syndrome(SBS) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Short Bowel Syndrome(SBS) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Short Bowel Syndrome(SBS) Market Share by Region: 2021 VS 2028
Figure 12. Global Short Bowel Syndrome(SBS) Market Share by Players in 2021
Figure 13. Global Top Short Bowel Syndrome(SBS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome(SBS) as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Short Bowel Syndrome(SBS) Revenue in 2021
Figure 15. North America Short Bowel Syndrome(SBS) Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Short Bowel Syndrome(SBS) Market Size Market Share by Type (2017-2028)
Figure 17. North America Short Bowel Syndrome(SBS) Market Size Market Share by Sale Channel (2017-2028)
Figure 18. North America Short Bowel Syndrome(SBS) Market Size Share by Country (2017-2028)
Figure 19. United States Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Short Bowel Syndrome(SBS) Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Short Bowel Syndrome(SBS) Market Size Market Share by Type (2017-2028)
Figure 23. Europe Short Bowel Syndrome(SBS) Market Size Market Share by Sale Channel (2017-2028)
Figure 24. Europe Short Bowel Syndrome(SBS) Market Size Share by Country (2017-2028)
Figure 25. Germany Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Short Bowel Syndrome(SBS) Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Short Bowel Syndrome(SBS) Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Short Bowel Syndrome(SBS) Market Size Market Share by Sale Channel (2017-2028)
Figure 34. Asia Pacific Short Bowel Syndrome(SBS) Market Size Share by Region (2017-2028)
Figure 35. China Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Short Bowel Syndrome(SBS) Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Short Bowel Syndrome(SBS) Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Short Bowel Syndrome(SBS) Market Size Market Share by Sale Channel (2017-2028)
Figure 44. Latin America Short Bowel Syndrome(SBS) Market Size Share by Country (2017-2028)
Figure 45. Mexico Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Short Bowel Syndrome(SBS) Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Short Bowel Syndrome(SBS) Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Short Bowel Syndrome(SBS) Market Size Market Share by Sale Channel (2017-2028)
Figure 50. Middle East and Africa Short Bowel Syndrome(SBS) Market Size Share by Country (2017-2028)
Figure 51. Turkey Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Short Bowel Syndrome(SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Merck Revenue Growth Rate in Short Bowel Syndrome(SBS) Business (2017-2022)
Figure 55. Takeda Revenue Growth Rate in Short Bowel Syndrome(SBS) Business (2017-2022)
Figure 56. Emmaus Medical Revenue Growth Rate in Short Bowel Syndrome(SBS) Business (2017-2022)
Figure 57. Ardelyx Revenue Growth Rate in Short Bowel Syndrome(SBS) Business (2017-2022)
Figure 58. Naia Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome(SBS) Business (2017-2022)
Figure 59. Nutrinia Revenue Growth Rate in Short Bowel Syndrome(SBS) Business (2017-2022)
Figure 60. OxThera Revenue Growth Rate in Short Bowel Syndrome(SBS) Business (2017-2022)
Figure 61. Sancilio Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome(SBS) Business (2017-2022)
Figure 62. Zealand Pharma Revenue Growth Rate in Short Bowel Syndrome(SBS) Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs